---
title: "EBR Systems Updates Director Holdings After Reverse Stock Split"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282608367.md"
description: "EBR Systems, Inc. has updated the security holdings of director Allan Will following a reverse stock split on April 10, 2026. The split reduced the number of options and warrants held by Will, while his and partner Taphne Lux’s holdings of CHESS depository interests remained unchanged. This adjustment reflects a technical restructuring with no cash involved. The filing enhances transparency regarding governance and ownership concentration. The latest analyst rating for EBR stock is a Buy with a price target of A$2.47, and the company focuses on developing implantable cardiac pacing systems."
datetime: "2026-04-14T01:09:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282608367.md)
  - [en](https://longbridge.com/en/news/282608367.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282608367.md)
---

# EBR Systems Updates Director Holdings After Reverse Stock Split

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) is now available.

EBR Systems, Inc. has disclosed changes in the security holdings of director Allan Will following the completion of a reverse stock split implemented on 10 April 2026. The adjustment significantly reduced the number of options and warrants held directly by Will, while his and his partner Taphne Lux’s holdings of CHESS depository interests remain unchanged, reflecting a technical restructuring rather than a new investment or divestment.

The notice underscores that the change in Will’s relevant interests arises purely from the corporate action, with no cash consideration involved. For investors, the filing clarifies the post-split capital position of a key director, enhancing transparency around governance and ownership concentration as the company recalibrates its share structure.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.47 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

**More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh**

EBR Systems, Inc. is a medical technology company focused on developing and commercializing implantable cardiac pacing systems. The company targets patients with heart rhythm disorders, providing innovative device-based therapies that are typically listed and traded on the Australian Securities Exchange via CHESS depository interests.

**Average Trading Volume:** 533,249

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$301.7M

See more data about EBR stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [EBR.US](https://longbridge.com/en/quote/EBR.US.md)

## Related News & Research

- [EBR Systems to Spotlight Wireless Cardiac Pacing at Canaccord Growth Conference](https://longbridge.com/en/news/294747038.md)
- [Bell Potter Reaffirms Their Buy Rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR)](https://longbridge.com/en/news/294161699.md)
- [Lexeo Therapeutics releases corporate presentation outlining cardiac gene therapy pipeline, AAVrh.10 platform](https://longbridge.com/en/news/295657284.md)
- [Stocks in Play: Ventripoint Diagnostics Ltd](https://longbridge.com/en/news/295677460.md)
- [Arch Biopartners expands Phase II LSALT peptide trial for cardiac surgery-related acute kidney injury to US](https://longbridge.com/en/news/295531014.md)